Latest Breaking News On - Leonard meron biosciences - Page 1 : comparemela.com

Veteran Citius CEO Uses All-In Approach to Bring New Treatments to Market

Veteran Citius CEO Uses All-In Approach to Bring New Treatments to Market
healthleadersmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthleadersmedia.com Daily Mail and Mail on Sunday newspapers.

United statesTemple universityCitius pharmaLeonard mazurMyron holubiakHelena mazur hallAnderson hallKnoll pharmaLeonard meron biosciencesCollege of liberal artsAkrimax pharmaceuticalsMedicis pharmaceutical corporationCooper laboratoryCitius pharmaceuticalsGenesis pharmaceuticalsCatholic prep high school

Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial | Gastroenterology | JAMA

This study examines adverse events and durability of response of SER-109, an investigational microbiome therapeutic comprised of purified Firmicutes spores, com

United kingdomUnited statesBarbarah mcgovernLeonard meron biosciencesKristin walterJodyw zylkeJeffrey williamsSteven omarroAasim sheikhDoria grimardJanssen researchRegeneron pharmaceuticalsSciences incGenentech incGenesis researchMd summit clinical research

Citius Pharmaceuticals Announces Key Management Realignment to Support Commercialization of Two Late-Stage Product Candidates

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development.

United statesIlanit allenJaime bartushakMyron holubiakJamie bartushakMichael mcguireLeonard mazurLeonard meron biosciencesCompany nasdaqMedicines companyBiomedical advanced researchProgram leader for antiDevelopment authorityExchange commissionGovernment affairsCenters for medicare

Citius Pharma restructures management team

Citius Pharmaceuticals Inc. is realigning its management team to strengthen its commercial capabilities, the Cranford biopharmaceutical company announced April 13.

Jaime bartushakMyron holubiakMichael mcguireLeonard mazurLeonard meron biosciencesMedicines coCitius pharmaceuticals incCitius pharmaceuticalsExecutive chairman leonard mazurChief financial officer jaime bartushakRoche laboratories

Temple University Renames College of Liberal Arts Main Campus Building in Honor of Citius Pharmaceuticals Executive Chairman Leonard Mazur

/PRNewswire/ Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development.

Temple universityUnited statesPierre fabreHelena mazur hallMazur hallLeonard mazurHelena mazurRichard deegGladfelter hallIlanit allenAnderson hallKnoll pharmaNovecite incCompany nasdaqGenesis pharmaceuticals incTemple university college of liberal arts